Artiva Biotherapeutics, Inc.
Biotechnology company · San Diego, California, United States · Nasdaq: ARTV
Artiva Biotherapeutics, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2019. Its shares trade on Nasdaq under the ticker ARTV. It has reported private securities offerings to the US SEC, most recently $120 million sold in a notice filed in 2021.
Artiva Biotherapeutics at a glance
What does Artiva Biotherapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $120 million sold (2021).
Frequently asked questions about Artiva Biotherapeutics
Where is Artiva Biotherapeutics headquartered?
Artiva Biotherapeutics, Inc. is headquartered in San Diego, California, United States.
What does Artiva Biotherapeutics do?
Artiva Biotherapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Artiva Biotherapeutics a public company?
Yes. Artiva Biotherapeutics, Inc. trades on Nasdaq under the ticker ARTV.
When was Artiva Biotherapeutics founded?
The earliest incorporation on record for Artiva Biotherapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- Biolinq IncSan Diego, California, United States
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.